Skip to search.
 TSX Down 0.40% TSX Ventures Up 0.34%

XOMA Corporation (XOMA)

-NasdaqGM
3.59 Down 0.11(2.97%) Mar 26, 4:00PM EDT
|After Hours : 3.59 0.00 (0.00%) Mar 26, 4:37PM EDT
Add to Portfolio
Prev Close:3.70
Open:3.67
Bid:3.61 x 5000
Ask:4.05 x 3000
1y Target Est:8.71
Beta:4.14
Earnings Date:May 5 - May 11 (Est.)
Day's Range:3.52 - 3.71
52wk Range:3.22 - 5.95
Volume:2,818,619
Avg Vol (3m):2,484,630
Market Cap:417.10M
P/E (ttm):N/A
EPS (ttm):-0.68
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
XOMADown 2.97%417.10M
NVSDown 0.80%238.81B
REGNDown 1.24%45.68B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):22.79
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.59
Quarterly EPS Est (Mar-15) :-0.16
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.37

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

XOMA Corporation discovers and develops antibody-based therapeutics in the United States, Europe, and the Asia Pacific. The company’s lead product candidate includes gevokizumab, a proprietary humanized allosteric-modulating monoclonal antibo... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback